We are live on ! Find out more
SCM

Suvretta Capital Management Portfolio holdings

AUM $3.92B
1-Year Est. Return 86.67%
This Fund
S&P 500
This Quarter Est. Return
+12.88%
1 Year Est. Return
+86.67%
3 Year Est. Return
+295.96%
5 Year Est. Return
+364.48%
10 Year Est. Return
+2,073.65%
AUM
$3.32B
AUM Growth
+$622M
Cap. Flow
+$387M
Cap. Flow %
11.66%
Top 10 Hldgs %
45.52%
Holding
112
New
12
Increased
30
Reduced
18
Closed
14

Top Buys

Rank Stock Value
1
KO icon
Coca-Cola
KO
+$58.2M
2
DKS icon
Dick's Sporting Goods
DKS
+$48.3M
3
GEHC icon
GE HealthCare
GEHC
+$37.1M
4
DHR icon
Danaher
DHR
+$31.2M
5
GE icon
GE Aerospace
GE
+$24M

Top Sells

Rank Stock Value
1
INSM icon
Insmed
INSM
+$95.9M
2
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$92.5M
3
MSFT icon
Microsoft
MSFT
+$35.3M
4
CMG icon
Chipotle Mexican Grill
CMG
+$27.1M
5
UAL icon
United Airlines
UAL
+$26.2M

Sector Composition

Rank Sector Weight
1 Healthcare 48.97%
2 Technology 9.89%
3 Consumer Discretionary 5.64%
4 Financials 4.91%
5 Communication Services 4.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ELV icon
101
Elevance Health
ELV
$85.4B
– –
-2,740
Closed -$1.19M
IRON icon
102
Disc Medicine
IRON
$2.96B
– –
-80,000
Closed -$3.97M
ORIC icon
103
Oric Pharmaceuticals
ORIC
$1.34B
– –
-255,000
Closed -$1.42M
RBLX icon
104
Roblox
RBLX
$26.4B
– –
-227,710
Closed -$13.3M
SNOW icon
105
Snowflake
SNOW
$113B
– –
-137,886
Closed -$20.2M
SNY icon
106
Sanofi
SNY
$104B
– –
-83,701
Closed -$4.64M
TRVI icon
107
Trevi Therapeutics
TRVI
$2.56B
– –
-340,164
Closed -$2.14M
TTWO icon
108
Take-Two Interactive
TTWO
$45.5B
– –
-72,400
Closed -$15M
U icon
109
Unity
U
$18.4B
– –
-339,560
Closed -$6.65M
BIOA
110
BioAge Labs
BIOA
$537M
– –
-1,452,336
Closed -$5.46M
AARD
111
Aardvark Therapeutics
AARD
$163M
– –
-312,500
Closed -$2.35M
ITCI
112
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-700,904
Closed -$92.5M
1 2 3 4
5

Similar funds

MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
MSI
Mitsui Sumitomo Insurance Tokyo, Japan $3.9B AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Suvretta Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Suvretta Capital Management held 112 positions worth $3.32B, up 23% from $2.69B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Suvretta Capital Management deployed $387M of net new capital in Q2 2025, opening 12 new positions and adding to 30 existing holdings. Its largest new stake was Dick's Sporting Goods: 260,465 shares worth $51.5M.

By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 60% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Insmed, an estimated $95.9M trimmed.

  • Suvretta Capital Management's largest Q2 2025 buy was Dick's Sporting Goods: 260,465 shares worth $51.5M.
  • Suvretta Capital Management added most to Coca-Cola in Q2 2025, an estimated $58.2M increase.
  • Suvretta Capital Management's biggest Q2 2025 reduction was Insmed, cutting an estimated $95.9M.
  • Suvretta Capital Management fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $92.5M.
  • Suvretta Capital Management's ten largest holdings make up 46% of its $3.32B portfolio in Q2 2025.
  • Suvretta Capital Management opened 12 new positions and closed 14 in Q2 2025.
  • Suvretta Capital Management's portfolio value rose 23% quarter-over-quarter to $3.32B.

Based on Suvretta Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.